Abstract
OBJECTIVE:To report a method for the determination of MS-551(MS) concentrations in plasma by HPLC.METHODS:MS was separated on a C18 column(5μm,4.6mm×15cm) by using methanol -0.1M ammonium acetate (60∶40) as mobile phase with detection wavelength at 270nm.Quantification was carried out based on the external standard of MS.RESULTS:There was a good linearity over the range from 0.1 to 2.0μg·ml-1 of MS,Y=8.6963×10-2+3.55×10-6X(r=0.9990).The average recovery was 94.27%.The detection limit was 0.85ng.At the same time,the relationship between the plasma concentrations of MS and QTc was determined in anaesthetized dogs with MS.CONCLUSION:This method is simple,practical and accurate.
Key words
MS-551 /
HPLC /
plasma concentration
{{custom_keyword}} /
Cite this article
Download Citations
Meng Ling .
Determination of MS-551 concentration in plasma by HPLC[J]. Chinese Pharmaceutical Journal, 1999, 34(11): 759-761
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 Katakami T,Yokoyama T,Miyamoto M,et al.Synthesis and pharmacologica studies of N-substituted 6-[(2-aminoethy)amino] 1,3-dimethyl2;4(1H,3H)-pyrimidinediones,novel class Ⅲ antiarrhythmic agents.J Med Chem,1992,35(18):3325.
2 Kamiya J,Ishii M,Katakami T.Antiarrhythmic effects of MS551,a new class Ⅲ antiarrhythrnic gaent,on canine models of ventricular arrhythmia.J pn J Pharmacol.1992,58(2):112.
3 Kondoh K,Hashimoto H,Nishiyama H,et al.Effects of MS-551,a new class Ⅲ antiarrhythmic drug,on programmed stimulation-induced ventricular arrhythmias,electropysiology,and hemodynamics in a canine myocardial infarction model.J Cardiovasc Pharmacol,1994,23(4):675.
4 Kamiya J,Ishii M,Yoshihara K,et al.MS-551:Pharmaoological profile of a novel class Ⅲ antiarrhythmie gaent.Drug Dev Res,1993,30(1):39.
{{custom_fnGroup.title_en}}
Footnotes
{{custom_fn.content}}